Haptoglobin-related protein as a serum marker in malignant lymphoma


A novel serum 21 kDa haptoglobin-related protein (Hpr) was investigated in patients with malignant lymphoma, to evaluate its correlation with clinical and histologic features at presentation and its possible role as a tumor marker for patient outcome. One hundred fifty eight serum samples were taken from 88 patients with non-Hodgkin’s lymphoma (n=58) and… (More)
DOI: 10.1007/BF02905217


5 Figures and Tables

Cite this paper

@article{Epelbaum1998HaptoglobinrelatedPA, title={Haptoglobin-related protein as a serum marker in malignant lymphoma}, author={Ron Epelbaum and Channa Shalitin and Ruth Segal and Clari Valansi and Ida Arselan and David Faraggi and Michelle Leviov and Menahem Ben-Shahar and N. Bar - Haim}, journal={Pathology & Oncology Research}, year={1998}, volume={4}, pages={271-276} }